Lymphocyte proliferative responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 8, 1996, Pages 697-704

  Mori, Hiromitsu ^a   Yabu, Koji ^a,b   Yoshizawa, Kaname ^a   Tanaka, Eiji ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD4 ANTIGEN; CD8 ANTIGEN; HEPATITIS C ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS RNA;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS HEPATITIS;

EID: 0029975764     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00317.x     Document Type: Article

References (33)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non B viral hepatitis genome. Science 1989; 244: 359-62.
2. Kato N, Hijikata M, Ootsuyama Y et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non B viral hepatitis. Proc. Natl Acad. Sci. USA 1990; 87: 9524-8.
3. Takamizawa A, Mori C, Fuke I et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 1991; 65: 1105-13.
4. Kuo G, Choo QL, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
5. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
6. Van der Poel CL, Reesink HW, Lelie PN et al. Antihepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 1989; ii: 297-8.
7. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: First-generation and second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992; 16: 300-5.
8. Saito M, Hasegawa A, Kashiwakuma T et al. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin. Chem. 1992; 38: 2434-9.
9. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347-53.
10. Tanaka E, Kiyosawa K, Matsushima T et al. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi-institution analysis. J. Gastroenterol. Hepatol. 1995; 10: 538-45.
11. Simmonds P, McOmish F, Yap PL et al. Sequence variability in the 5′ non coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. J. Gen. Virol. 1993; 74: 661-8.
12. Kohara M, Tsukiyama-Kohara K, Maki N et al. Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus. J. Gen. Virol. 1992; 73: 2313-19.
13. Meuer SC, Hussey RE, Cantrell DA et al. Triggering of the T3-Ti antigen receptor complex results in clonal T cell proliferation via an interleukin 2 dependent autocrine pathway. Proc. Natl Acad. Sci. USA 1984; 81: 1509-13.
14. Yabu K, Yano A. Antigen presentation by human antigen-presenting cells to antigen-specific xenogenetic murine T cells. Microbiol. Immunol. 1986; 30: 237-49.
15. Shirai M, Akatsuka T, Pendleton CD et al. Induction of cytotoxic T cells to a cross reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J. Virol. 1992; 66: 4098-106.
16. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. 1993; 178: 17-25.
17. Ulrich PP, Romeo JM, Lane PK, Kelly I, Daniel LJ, Vyas GN. Detection, semiquantitation, and genetic variation in hepatitis C virus sequence amplified from the plasma of blood donors with elevated alanine aminotransferase. J. Clin. Invest. 1990; 86: 1609-14.
18. Jenison SA, Lemon SM, Baker LN, Newbold JE. Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. J. Infect. Dis. 1987; 156: 299-307.
19. Hagiwara H, Hayashi N, Mita E et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993; 17: 545-50.
20. Kurosaki M, Enomoto N, Sato C et al. Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease. J. Med Virol. 1993; 39: 246-50.
21. Koziel MJ, Dudley D, Womg JT et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus with chronic hepatitis. J. Immunol. 1992; 149: 3339-44.
22. Weiner AJ, Brauer MJ, Rosenblatt J et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-9.
23. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl Acad. Sci. USA 1991; 88: 3392-6.
24. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun. 1991; 175: 220-9.
25. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 1992; 73: 673-9.
26. Kubo Y, Takeuchi K, Boonmar S et al. A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res. 1989; 17: 10 367-72.
27. Takeuchi K, Kubo Y, Boonmar S et al. The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J. Gen. Virol. 1990; 71: 3027-33.
28. Choo QL, Richman KH, Han JH, Ogata H, Kiyosawa K. Genetic organization and diversity of the hepatitis C virus. Proc. Natl Acad. Sci. USA 1991; 88: 2451-5.
29. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-alfa 2a therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 1994; 39: 1273-80.
30. Botarelli P, Brunetto MR, Minutello MA et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104: 580-7.
31. Schupper H, Hayashi P, Scheffel J. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 1993; 18: 1055-60.
32. Bertoletti A, Sette A, Chisari F et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T-cells. Nature 1994; 369: 407-10.
33. + T lymphocytes. Cell 1994; 77: 525-35.